About this item
Product details
Diampa-M XR is a high-potency, dual-combination extended-release tablet for the intensive management of type 2 diabetes in adults. It pairs the maximum therapeutic dose of Empagliflozin (25mg), an SGLT2 inhibitor, with a full 1000mg dose of Metformin in an extended-release (XR) formulation. This combination provides powerful dual-mechanism glucose-lowering: Empagliflozin increases urinary glucose excretion and offers proven cardiovascular and renal protection, while Metformin XR reduces liver glucose output with improved gastrointestinal tolerability. It is designed for patients requiring robust glycemic control in a convenient once-daily pill. Maximum SGLT2 Inhibition: The 25mg Empagliflozin dose provides the strongest level of glucose removal through urine. Dual & Powerful Action: Targets blood sugar from two angles for superior and sustained control. Cardio-Renal Protection: High-dose Empagliflozin is associated with significant reductions in heart failure hospitalization and kidney disease progression. Better Tolerability: The XR Metformin formulation minimizes common stomach upset. Composition Each Extended Release tablet contains: Empagliflozin: 25 mg Metformin HCI USP: 1000 mg Directions for Use As directed by the physician.
- Medicines
- 14 Extended Release Tablets
- 1 variant
- Protected Dastak checkout
Know before you buy
Specifications
- Department
- Health
- Subcategory
- Medicines
- Brand
- Getz Pharma
- SKU
- 8964002869336
- Variant
- 14 Extended Release Tablets
- Tags
- Empagliflozin, Medicine, Metformin
- Condition
- New
Customer feedback
Ratings & reviews
For help with a purchase, open your orders or contact Dastak support.
